Fuller & Thaler Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-116
Closed -$37.8K 597
2024
Q1
$37.8K Hold
116
﹤0.01% 493
2023
Q4
$22.1K Hold
116
﹤0.01% 485
2023
Q3
$23.1K Sell
116
-79,039
-100% -$18.7M ﹤0.01% 433
2023
Q2
$22.6M Buy
79,155
+6,443
+9% +$1.79M 0.13% 174
2023
Q1
$15.8M Buy
72,712
+5,032
+7% +$980K 0.09% 193
2022
Q4
$13.9M Sell
67,680
-178
-0.3% -$45K 0.09% 186
2022
Q3
$18.9M Buy
67,858
+24
+0% +$6.1K 0.14% 162
2022
Q2
$13M Buy
+67,834
New +$12M 0.09% 186

Other funds holding SWAV

Fuller & Thaler Asset Management's SWAV Position: Q2 2024 in Review

Fuller & Thaler Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 116 shares — an estimated $37.8K sold.

Fuller & Thaler Asset Management first reported a position in SWAV in Q2 2022 and held it in 8 quarters. The position peaked at $22.6M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Fuller & Thaler Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 116 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $37.8K.
  • Fuller & Thaler Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Fuller & Thaler Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $22.6M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2024, filed 9 Aug 2024.